AI assistant
Sending…
LEMAITRE VASCULAR INC — Director's Dealing 2020
May 21, 2020
31708_dirs_2020-05-21_aa392215-d37b-4974-996c-76ea03669a5e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2020-04-28
Reporting Person: Ross Bridget A (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-04-28 | Stock Option (Right to Buy) | $30 | J | 20000 | Acquired | 2025-04-28 | Common Stock (20000) | Direct |
| 2020-05-19 | Stock Option (Right to Buy) | $30 | J | 20000 | Disposed | 2025-04-28 | Common Stock (20000) | Direct |
| 2020-05-19 | Stock Option (Right to Buy) | $30 | A | 20000 | Acquired | 2025-04-28 | Common Stock (20000) | Direct |
Footnotes
F1: Grant of stock option by compensation committee
F2: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years.
F3: Rescission of stock option by compensation committee prior to acceptance of grant
More from LEMAITRE VASCULAR INC
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 14
Regulatory Filings
2026
Apr 14
Annual Report
2026
Apr 14
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3